Notice2026-04783
Citric Acid and Certain Citrate Salts From Canada and India; Determinations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 12, 2026
Issuing agencies
International Trade Commission
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 48 (Thursday, March 12, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 48 (Thursday, March 12, 2026)]
[Notices]
[Pages 12217-12218]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-04783]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 701-TA-783-784 and 731-TA-1771-1772 (Preliminary)]
Citric Acid and Certain Citrate Salts From Canada and India;
Determinations
On the basis of the record \1\ developed in the subject
investigations, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that there is a reasonable indication that an industry in the
United States is materially injured by reason of imports of citric acid
and certain citrate salts from Canada and India, provided for in
subheadings 2918.14.00, 2918.15.10, 2918.15.50, and 3824.99.93 of the
Harmonized Tariff Schedule of the United States, that are alleged to be
sold in the United States at less than fair value (``LTFV'') and
imports of the subject merchandise from Canada and India that are
alleged to be subsidized by the governments of Canada and India.\2\
---------------------------------------------------------------------------
\1\ The record is defined in Sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
\2\ 91 FR 7252 and 7257 (February 17, 2026).
---------------------------------------------------------------------------
Commencement of Final Phase Investigations
Pursuant to section 207.18 of the Commission's rules, the
Commission also gives notice of the commencement of the final phase of
its investigations. The Commission will issue a final phase notice of
scheduling, which will be published in the Federal Register as
[[Page 12218]]
provided in Sec. 207.21 of the Commission's rules, upon notice from
the U.S. Department of Commerce (``Commerce'') of affirmative
preliminary determinations in the investigations under Sec. Sec.
703(b) or 733(b) of the Act, or, if the preliminary determinations are
negative, upon notice of affirmative final determinations in those
investigations under Sec. Sec. 705(a) or 735(a) of the Act. Parties
that filed entries of appearance in the preliminary phase of the
investigations need not enter a separate appearance for the final phase
of the investigations. Any other party may file an entry of appearance
for the final phase of the investigations after publication of the
final phase notice of scheduling. Industrial users, and, if the
merchandise under investigation is sold at the retail level,
representative consumer organizations have the right to appear as
parties in Commission antidumping and countervailing duty
investigations. The Secretary will prepare a public service list
containing the names and addresses of all persons, or their
representatives, who are parties to the investigations. As provided in
section 207.20 of the Commission's rules, the Director of the Office of
Investigations will circulate draft questionnaires for the final phase
of the investigations to parties to the investigations, placing copies
on the Commission's Electronic Document Information System (EDIS,
<a href="https://edis.usitc.gov">https://edis.usitc.gov</a>), for comment.
Background
On January 21, 2026, Archer-Daniels-Midland Company, Decatur,
Illinois; Cargill, Incorporated, Wayzata, Minnesota; and Primary
Products Ingredients Americas LLC, Schaumburg, Illinois, filed
petitions with the Commission and Commerce, alleging that an industry
in the United States is materially injured or threatened with material
injury by reason of subsidized imports of citric acid and certain
citrate salts from Canada and India and LTFV imports of citric acid and
certain citrate salts from Canada and India. Accordingly, effective
January 21, 2026, the Commission instituted countervailing duty
investigation Nos. 701-TA-783-784 and antidumping duty investigation
Nos. 731-TA-1771-1772 (Preliminary).
Notice of the institution of the Commission's investigations and of
a public conference to be held in connection therewith was given by
posting copies of the notice in the Office of the Secretary, U.S.
International Trade Commission, Washington, DC, and by publishing the
notice in the Federal Register of January 26, 2026 (91 FR 3221). The
Commission conducted its conference on February 11, 2026. All persons
who requested the opportunity were permitted to participate.
The Commission made these determinations pursuant to Sec. Sec.
703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It
completed and filed its determinations in these investigations on March
9, 2026. The views of the Commission are contained in USITC Publication
5716 (March 2026), entitled Citric Acid and Certain Citrate Salts from
Canada and India: Investigation Nos. 701-TA-783-784 and 731-TA-1771-
1772 (Preliminary).
By order of the Commission.
Issued: March 9, 2026.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2026-04783 Filed 3-11-26; 8:45 am]
BILLING CODE 7020-02-P
</pre></body>
</html>Indexed from Federal Register on March 12, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.